ArticleWellcome open research2026
VALIDATION OF A BEHAVIOURAL, SPEECH SPECTRUM/SPEECH BASED mHEALTH HEARING SCREENER FOR CHILDREN.
Article in Wellcome open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An affordable mHealth-based subjective hearing screener (SRESHT) for children was developed to support contextualized hearing screening for developing countries. The screener was developed with calibrated commercial headphones and speakers at 60 dB HL with the target goal of identifying children with moderately severe or above degrees of disability (WH0, 2019). The hearing screener includes Behavioral Observation Audiometry (BOA) based screening module (0 to 1 year of age), Speech Spectrum Awareness Task (SSAT) module (1 to 3 years of age), Speech Recognition Task (SRT) module (3 to 6 years of age) and High Risk register (HRR) and Parental Questionnaire (PQ) module (0 to 6 years). The study identified optimal screening modules for detecting hearing loss = 60 dB HL for 0-1 year of age, 1 to 3 years of age and 3 to 6 years of age separately. For infants aged 0-1 year, the combined BOA+HRR module was found to be most suitable (SEN = 86%, SPE = 91%, ACU = 90%). In children aged 1-3 years, SSAT module was found to be suitable (SEN = 98%, SPE = 85%, ACU = 91.2%. For the 3-6 years age group, SRT was found suitable (SEN =95%, SPE = 89%, ACU = 91.43%). When test-based screening methods are not feasible, standalone HRR (0-1 year) and PQ (3-6 years) modules remain viable alternatives, meeting the 80% sensitivity and specificity benchmarks to screen for > = 60dBHL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.